# A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors

> **NCT00186901** · PHASE3 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 429 (actual)

## Conditions studied

- Leukemia, Lymphoblastic, Acute
- Osteoporosis

## Interventions

- **DRUG:** Calcium carbonate (Tums), vitamin D
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00186901
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2009-06
- **Final completion:** 2011-09
- **Target enrollment:** 429 (ACTUAL)
- **Last updated:** 2017-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00186901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00186901, "A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00186901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*